Ambac Financial Group (OSG) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Dec, 2025Executive summary
Specialty P&C premium rose 88% to $265 million in Q4 2024 and 74% to $876 million for 2024, with consolidated revenue up 89% to $236 million for the year, driven by acquisitions and organic growth.
Acquired Beat Capital Partners and launched six new MGAs in 2024, expanding scale and capabilities in MGA and delegated authority platform.
Sold legacy financial guarantee business to Oaktree for $420 million, resulting in a $570 million loss and consolidated net loss of $548 million for Q4.
Substantially completed separation of legacy and P&C businesses, including financial and technology platforms.
Adjusted EBITDA to Ambac common stockholders was $5 million for Q4 and $13 million for 2024, with only 5 months of consolidated Beat results included.
Financial highlights
P&C business generated nearly $900 million in premiums, up 74% year-over-year, and $236 million in revenue, up 89%.
Cirrata revenue reached $99 million for 2024, up 93%, with Adjusted EBITDA of $20 million and margin of 20%.
Everspan gross premium written grew to $383 million, up 40% year-over-year; combined ratio improved to 101.6% for the year.
Q4 2024 net loss was $548 million, or $10.23 per diluted share, primarily due to a $570 million loss on sale of discontinued operations.
Net loss from continuing operations attributable to common shareholders was $22 million for Q4 and $59 million for the year.
Outlook and guidance
2028 Adjusted EBITDA to Ambac target is $80–$90 million, up from $18 million in 2024, driven by organic growth, acquisitions, and Everspan contribution.
2025 guidance to be revisited after closing the legacy business sale; management expects a strong pipeline for organic and strategic growth.
Latest events from Ambac Financial Group
- Q4 2025 delivered strong premium and revenue growth, but net loss rose on acquisition costs.OSG
Q4 202524 Feb 2026 - AAC sale and Beat acquisition accelerate specialty P&C transformation and capital redeployment.OSG
Q2 20242 Feb 2026 - Legacy business sold to Oaktree and 60% of Beat acquired, accelerating specialty P&C focus.OSG
Investor Update31 Jan 2026 - Q3 net loss, 86% P&C premium growth, Beat acquisition, $50M buyback, legacy sale approved.OSG
Q3 202414 Jan 2026 - Revenue up 27% and P&C premium up 70%, but net loss widened on higher expenses.OSG
Q1 20257 Jan 2026 - Vote on $420M sale of AAC to Oaktree, executive pay, and adjournment; board recommends approval.OSG
Proxy Filing2 Dec 2025 - Shareholders to vote on $420M sale, board-backed, with new capital and governance terms.OSG
Proxy Filing2 Dec 2025 - Transformational year with strategic transactions, strong specialty insurance growth, and enhanced governance.OSG
Proxy Filing2 Dec 2025 - Vote requested on sale of Ambac Assurance Corporation and related executive compensation.OSG
Proxy Filing2 Dec 2025